Back to Companies
Ernexa Therapeutics Inc.
ERNANasdaqCIK: 0000748592
Ernexa Therapeutics Inc. (ERNA) shows 9 recent insider filings from 8 insiders, with all of them on the buy side. With $2.0M in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $2.0M). Cherington Charles (10% Owner) is the most active by dollar volume, and the single largest transaction was $4.7M by Cherington Charles. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$5.5M
Purchases
$2.0M
Sales
$0
Unique Insiders
8
Recent Insider Trades
9 loaded
| Sep 22 | ERNA Ernexa Therapeutics Inc. | Spiegel Robert J. | Director | Other | $0 |
| Sep 1 | ERNA Ernexa Therapeutics Inc. | Bristol James Arthur | Director | Award | $61.3K |
| Sep 1 | ERNA Ernexa Therapeutics Inc. | Cicala Peter | Director | Award | $50.4K |
| Sep 1 | ERNA Ernexa Therapeutics Inc. | Polinsky David | Director | Award | $23.2K |
| Sep 1 | ERNA Ernexa Therapeutics Inc. | Ratner Elena | Director | Award | $27.2K |
| Sep 1 | ERNA Ernexa Therapeutics Inc. | Luther Sanjeev | President and CEO, Director | Award | $543.1K |
| Sep 1 | ERNA Ernexa Therapeutics Inc. | Wexler William A. | Director | Award | $27.2K |
| Aug 27 | ERNA Ernexa Therapeutics Inc. | Polinsky David | Director | Other | $0 |
| Feb 17 | ERNA Ernexa Therapeutics Inc. | Cherington Charles | 10% Owner | Buy | $2.0M |
9 filings